Alahmadi, Ziad
Cervantes, C. Elena
Hanouneh, Mohamad
Article History
Received: 29 October 2025
Accepted: 26 January 2026
First Online: 20 February 2026
Declarations
:
: Not applicable.
: Written informed consent for publication of their clinical details and/or clinical images was obtained from the patient. A copy of the consent form is available for review by the Editor of this journal.
: Mohamad Hanouneh reports serving on a speaker’s bureau for Bayer, Novo Nordisk, Lilly and Boehringer Ingelheim. The remaining authors have nothing to disclose.
: The authors declare no competing interests.